Published in Circulation on July 02, 2002
Mortality risk among children initially treated with dialysis for end-stage kidney disease, 1990-2010. JAMA (2013) 2.74
Relationship of estimated GFR and coronary artery calcification in the CRIC (Chronic Renal Insufficiency Cohort) Study. Am J Kidney Dis (2011) 2.25
Growth hormone treatment started in the first year of life in infants with chronic renal failure. Pediatr Nephrol (2009) 2.21
Phosphate feeding induces arterial medial calcification in uremic mice: role of serum phosphorus, fibroblast growth factor-23, and osteopontin. Kidney Int (2009) 1.77
Long-term outcome of chronic dialysis in children. Pediatr Nephrol (2008) 1.72
Con: Phosphate binders in chronic kidney disease. Nephrol Dial Transplant (2015) 1.72
Coronary artery calcium screening: current status and recommendations from the European Society of Cardiac Radiology and North American Society for Cardiovascular Imaging. Int J Cardiovasc Imaging (2008) 1.67
Cardiovascular disease in children with chronic kidney disease. J Am Soc Nephrol (2012) 1.58
Vitamin D deficiency is associated with subclinical carotid atherosclerosis: the Northern Manhattan study. Stroke (2011) 1.57
Sevelamer hydrochloride: an effective phosphate binder in dialyzed children. Pediatr Nephrol (2003) 1.49
Cinacalcet HCl and concurrent low-dose vitamin D improves treatment of secondary hyperparathyroidism in dialysis patients compared with vitamin D alone: the ACHIEVE study results. Clin J Am Soc Nephrol (2008) 1.47
Predictors of blood pressure and its control in pediatric patients receiving dialysis. J Pediatr (2011) 1.46
Inflammation in chronic kidney disease: role in the progression of renal and cardiovascular disease. Pediatr Nephrol (2008) 1.29
Timing and outcome of renal replacement therapy in patients with congenital malformations of the kidney and urinary tract. Clin J Am Soc Nephrol (2012) 1.24
The Cardiovascular Comorbidity in Children with Chronic Kidney Disease (4C) study: objectives, design, and methodology. Clin J Am Soc Nephrol (2010) 1.21
Coronary artery calcifications in children with end-stage renal disease. Pediatr Nephrol (2006) 1.21
Nanoparticle-based test measures overall propensity for calcification in serum. J Am Soc Nephrol (2012) 1.20
Calcification in atherosclerosis. Nat Rev Cardiol (2009) 1.20
Inflammation and cachexia in chronic kidney disease. Pediatr Nephrol (2010) 1.20
Elevated FGF 23 and phosphorus are associated with coronary calcification in hemodialysis patients. Pediatr Nephrol (2011) 1.18
Hemodialysis in children: general practical guidelines. Pediatr Nephrol (2005) 1.16
Cardiovascular complications of pediatric chronic kidney disease. Pediatr Nephrol (2006) 1.12
Chronic kidney disease mineral and bone disorder in children. Pediatr Nephrol (2007) 1.11
Prevention and treatment of renal osteodystrophy in children on chronic renal failure: European guidelines. Pediatr Nephrol (2005) 1.09
Cardiovascular disease as a late complication of end-stage renal disease in children. Pediatr Nephrol (2004) 1.08
Cardiovascular disease in children with CKD or ESRD. Nat Rev Nephrol (2009) 1.06
Coronary artery calcium screening: current status and recommendations from the European Society of Cardiac Radiology and North American Society for Cardiovascular Imaging. Eur Radiol (2008) 1.06
Vascular calcification: pathophysiology and risk factors. Curr Hypertens Rep (2012) 1.06
Increased intima-media thickness of the carotid artery in childhood: a systematic review of observational studies. Eur J Pediatr (2010) 1.05
Factors associated with coronary artery calcification in young female patients with SLE. Ann Rheum Dis (2003) 1.05
Phosphate is a vascular toxin. Pediatr Nephrol (2012) 1.05
Cardiovascular disease in CKD in children: update on risk factors, risk assessment, and management. Am J Kidney Dis (2009) 1.01
The demise of calcium-based phosphate binders-is this appropriate for children? Pediatr Nephrol (2014) 0.99
Intima-media thickness measurements in children with cardiovascular risk factors. Pediatr Nephrol (2008) 0.99
Dyslipidemia in children with chronic kidney disease. Kidney Int (2010) 0.99
Psychosocial rehabilitation and satisfaction with life in adults with childhood-onset of end-stage renal disease. Pediatr Nephrol (2005) 0.99
Severe cardiac hypertrophy and long-term dialysis: the Midwest Pediatric Nephrology Consortium study. Pediatr Nephrol (2006) 0.98
What parathyroid hormone levels should we aim for in children with stage 5 chronic kidney disease; what is the evidence? Pediatr Nephrol (2007) 0.98
Cardiovascular complications in children with chronic kidney disease. Nat Rev Nephrol (2011) 0.98
Cinacalcet for secondary hyperparathyroidism in children with end-stage renal disease. Pediatr Nephrol (2008) 0.97
Lipoprotein metabolism in chronic renal insufficiency. Pediatr Nephrol (2007) 0.96
Current advances in chronic kidney disease in children: growth, cardiovascular, and neurocognitive risk factors. Semin Nephrol (2009) 0.96
Intima-media thickness and arterial elasticity in hypertensive children: controlled study. Pediatr Nephrol (2004) 0.94
Cardiovascular risk assessment among potential kidney transplant candidates: approaches and controversies. Am J Kidney Dis (2009) 0.94
Reduction of left ventricular hypertrophy in children undergoing hemodialysis. Pediatr Nephrol (2006) 0.94
Modulation of vitamin D signaling is a potential therapeutic target to lower cardiovascular risk in chronic kidney disease. Med Sci Monit (2011) 0.92
Noninvasive imaging for assessment of calcification in chronic kidney disease. Nat Rev Nephrol (2011) 0.91
Pathogenesis of vascular calcification in dialysis patients. Clin Exp Nephrol (2005) 0.91
Serum fetuin-A levels are associated with vascular calcifications and predict cardiovascular events in renal transplant recipients. Clin J Am Soc Nephrol (2011) 0.91
Body composition and nutritional intake in children with chronic kidney disease. Pediatr Nephrol (2006) 0.91
CD70 Exacerbates Blood Pressure Elevation and Renal Damage in Response to Repeated Hypertensive Stimuli. Circ Res (2016) 0.91
Arterial calcifications. J Cell Mol Med (2010) 0.90
HDL in children with CKD promotes endothelial dysfunction and an abnormal vascular phenotype. J Am Soc Nephrol (2014) 0.90
Traditional and "new" cardiovascular risk markers and factors in pediatric dialysis patients. Pediatr Nephrol (2007) 0.90
Pathogenesis of chronic cardiorenal syndrome: is there a role for oxidative stress? Int J Mol Sci (2013) 0.89
Circulating angiopoietin-2 is a marker for early cardiovascular disease in children on chronic dialysis. PLoS One (2013) 0.89
Relation of serum fetuin-A levels to coronary artery calcium in African-American patients on chronic hemodialysis. Am J Cardiol (2008) 0.89
Progression of coronary calcification in pediatric chronic kidney disease stage 5. Pediatr Nephrol (2008) 0.89
Coronary artery calcification in chronic kidney disease: An update. World J Cardiol (2014) 0.88
Treatment strategies in patients with chronic renal disease: ACE inhibitors, angiotensin receptor antagonists, or both? Pediatr Nephrol (2004) 0.87
[Atherosclerosis and uremia: signifance of non-traditional risk factors]. Wien Klin Wochenschr (2003) 0.86
Dephosphorylated-uncarboxylated Matrix Gla protein concentration is predictive of vitamin K status and is correlated with vascular calcification in a cohort of hemodialysis patients. BMC Nephrol (2014) 0.86
Arterial stiffness in children after renal transplantation. Pediatr Nephrol (2008) 0.86
Changes of blood pressure and left ventricular mass in pediatric renal transplantation. Pediatr Nephrol (2004) 0.86
Growth in children with chronic renal failure on intermittent versus daily calcitriol. Pediatr Nephrol (2003) 0.86
Chapter 4: Other complications of CKD: CVD, medication dosage, patient safety, infections, hospitalizations, and caveats for investigating complications of CKD. Kidney Int Suppl (2011) (2013) 0.86
Uraemic vasculopathy in children with chronic kidney disease: prevention or damage limitation? Pediatr Nephrol (2010) 0.85
Impact of inflammation and oxidative stress on vascular calcifications in chronic kidney disease. Pediatr Nephrol (2004) 0.85
Renal function is related to severity of coronary artery calcification in elderly persons: the Rotterdam study. PLoS One (2011) 0.85
The relation between serum phosphorus levels and clinical outcomes after acute myocardial infarction. PLoS One (2013) 0.85
Chronic kidney disease and inflammation in pediatric patients: from bench to playground. Pediatr Nephrol (2005) 0.84
Vitamin D deficiency and arterial wall stiffness in children with chronic kidney disease. Pediatr Cardiol (2011) 0.84
Cardiovascular calcifications in pediatric patients receiving maintenance dialysis. Pediatr Nephrol (2003) 0.84
The interdialytic weight gain: a simple marker of left ventricular hypertrophy in children on chronic haemodialysis. Pediatr Nephrol (2015) 0.84
Chronic kidney disease: mineral and bone disorder in children. Semin Nephrol (2013) 0.84
Peritoneal dialysis tailored to pediatric needs. Int J Nephrol (2011) 0.84
Catch-up growth with normal parathyroid hormone levels in chronic renal failure. Pediatr Nephrol (2003) 0.84
Defining left ventricular hypertrophy in children on peritoneal dialysis. Clin J Am Soc Nephrol (2011) 0.83
Can bisphosphonates play a role in the treatment of children with chronic kidney disease? Pediatr Nephrol (2011) 0.83
Urinary and dialysate losses of vitamin D-binding protein in children on chronic peritoneal dialysis. Pediatr Nephrol (2011) 0.83
Assessment of the cardiovascular system in pediatric chronic kidney disease: a pilot study. Pediatr Nephrol (2008) 0.83
Carotid artery thickness in children and young adults with end stage renal disease. Pediatr Nephrol (2006) 0.83
Continuous ambulatory peritoneal dialysis patients show high prevalence of carotid artery calcification which is associated with a higher left ventricular mass index. J Korean Med Sci (2005) 0.82
Association of Serum Phosphate and Related Factors in ESRD-Related Vascular Calcification. Int J Nephrol (2011) 0.82
Advanced Parameters of Cardiac Mechanics in Children with CKD: The 4C Study. Clin J Am Soc Nephrol (2015) 0.82
Elevated serum bone morphogenetic protein 4 in patients with chronic kidney disease and coronary artery disease. J Cardiovasc Transl Res (2012) 0.82
Chapter 5: Referral to specialists and models of care. Kidney Int Suppl (2011) (2013) 0.82
Are new vitamin D analogues in renal bone disease superior to calcitriol? Pediatr Nephrol (2005) 0.82
"Missing" inhibitors of calcification: general aspects and implications in renal failure. Pediatr Nephrol (2004) 0.82
The malnutrition and inflammation axis in pediatric patients with chronic kidney disease. Pediatr Nephrol (2007) 0.82
Educational paper: Progression in chronic kidney disease and prevention strategies. Eur J Pediatr (2012) 0.82
Characterisation of calcium phosphate crystals on calcified human aortic vascular smooth muscle cells and potential role of magnesium. PLoS One (2015) 0.82
Cardiovascular risk assessment in children with chronic kidney disease. Pediatr Nephrol (2012) 0.81
Left ventricular diastolic dysfunction by tissue Doppler echocardiography in pediatric chronic kidney disease. Pediatr Nephrol (2013) 0.81
Report of an NIH task force on research priorities in chronic kidney disease in children. Pediatr Nephrol (2005) 0.81
Renal function, uraemia and early arteriovenous fistula failure. BMC Nephrol (2014) 0.81
Solutions for peritoneal dialysis in children: recommendations by the European Pediatric Dialysis Working Group. Pediatr Nephrol (2011) 0.81
Hyperlipidemia, oxidative stress, and intima media thickness in children with chronic kidney disease. Pediatr Nephrol (2012) 0.81
Peritoneal dialysis in infants. Pediatr Nephrol (2006) 0.81
Mineral and bone disorders in children with chronic kidney disease. Nat Rev Nephrol (2011) 0.81
Peritoneal dialysis-related infections recommendations: 2010 update. Perit Dial Int (2010) 12.06
Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients. Kidney Int (2002) 9.29
From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I. Circulation (2003) 8.61
Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis. Nat Med (2011) 6.35
Long-term prognosis associated with coronary calcification: observations from a registry of 25,253 patients. J Am Coll Cardiol (2007) 5.91
Strict blood-pressure control and progression of renal failure in children. N Engl J Med (2009) 5.71
Peritoneal dialysis-related infections recommendations: 2005 update. Perit Dial Int (2005) 5.49
Effect of calcium-based versus non-calcium-based phosphate binders on mortality in patients with chronic kidney disease: an updated systematic review and meta-analysis. Lancet (2013) 4.58
Premature coronary-artery atherosclerosis in systemic lupus erythematosus. N Engl J Med (2003) 4.58
From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II. Circulation (2003) 3.94
Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis. Kidney Int (2005) 3.71
Prognostic value of cardiac risk factors and coronary artery calcium screening for all-cause mortality. Radiology (2003) 3.70
Eculizumab in severe Shiga-toxin-associated HUS. N Engl J Med (2011) 3.28
Distribution of 24-h ambulatory blood pressure in children: normalized reference values and role of body dimensions. J Hypertens (2002) 3.21
Increased coronary-artery atherosclerosis in rheumatoid arthritis: relationship to disease duration and cardiovascular risk factors. Arthritis Rheum (2005) 3.17
Management of high blood pressure in children and adolescents: recommendations of the European Society of Hypertension. J Hypertens (2009) 3.13
Increased concentration of proatherogenic inflammatory cytokines in systemic lupus erythematosus: relationship to cardiovascular risk factors. J Rheumatol (2006) 3.10
Recessive mutations in DGKE cause atypical hemolytic-uremic syndrome. Nat Genet (2013) 2.91
Prevalence of mutations in renal developmental genes in children with renal hypodysplasia: results of the ESCAPE study. J Am Soc Nephrol (2006) 2.89
Absence of coronary artery calcification and all-cause mortality. JACC Cardiovasc Imaging (2009) 2.86
Circulating suPAR in two cohorts of primary FSGS. J Am Soc Nephrol (2012) 2.83
MYO1E mutations and childhood familial focal segmental glomerulosclerosis. N Engl J Med (2011) 2.65
Progression of coronary artery calcium predicts all-cause mortality. JACC Cardiovasc Imaging (2010) 2.48
Serum 25-hydroxyvitamin D levels and the prevalence of peripheral arterial disease: results from NHANES 2001 to 2004. Arterioscler Thromb Vasc Biol (2008) 2.32
Carotid artery intima-media thickness and distensibility in children and adolescents: reference values and role of body dimensions. Hypertension (2013) 2.31
SIX2 and BMP4 mutations associate with anomalous kidney development. J Am Soc Nephrol (2008) 2.30
Drug dosing consideration in patients with acute and chronic kidney disease-a clinical update from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int (2011) 2.28
Chronic kidney disease in adolescent and adult patients with phenylketonuria. J Inherit Metab Dis (2012) 2.15
Sex differences in mental stress-induced myocardial ischemia in young survivors of an acute myocardial infarction. Psychosom Med (2014) 2.12
Coronary aging in HIV-infected patients. Clin Infect Dis (2009) 2.02
High prevalence of the metabolic syndrome in patients with systemic lupus erythematosus: association with disease characteristics and cardiovascular risk factors. Ann Rheum Dis (2006) 2.00
Diagnostic performance of fusion of myocardial perfusion imaging (MPI) and computed tomography coronary angiography. J Nucl Cardiol (2009) 1.99
Ethnic differences in the prognostic value of coronary artery calcification for all-cause mortality. J Am Coll Cardiol (2007) 1.99
Prognostic value of coronary artery calcium screening in asymptomatic smokers and non-smokers. Eur Heart J (2006) 1.96
Trends in ATP-III-defined high blood cholesterol prevalence, awareness, treatment and control among U.S. adults. Ann Epidemiol (2007) 1.84
Vascular calcification in chronic kidney disease. Am J Kidney Dis (2004) 1.81
Epicardial adipose tissue and coronary artery plaque characteristics. Atherosclerosis (2009) 1.77
Successful treatment of steroid-resistant nephrotic syndrome associated with WT1 mutations. Pediatr Nephrol (2010) 1.76
Systemic cardiovascular disease in uremic rats induced by 1,25(OH)2D3. J Hypertens (2005) 1.73
Heritability and seasonal variability of vitamin D concentrations in male twins. Am J Clin Nutr (2010) 1.73
Prevalence of the metabolic syndrome is increased in rheumatoid arthritis and is associated with coronary atherosclerosis. Atherosclerosis (2007) 1.73
Potential antiatherogenic and anti-inflammatory properties of sevelamer in maintenance hemodialysis patients. Am Heart J (2005) 1.72
Normative values for intima-media thickness and distensibility of large arteries in healthy adolescents. J Hypertens (2005) 1.70
Arterial and cardiac disease in young adults with childhood-onset end-stage renal disease-impact of calcium and vitamin D therapy. Nephrol Dial Transplant (2006) 1.67
Coronary artery calcium screening: current status and recommendations from the European Society of Cardiac Radiology and North American Society for Cardiovascular Imaging. Int J Cardiovasc Imaging (2008) 1.67
Effect of lifestyle intervention on features of polycystic ovarian syndrome, metabolic syndrome, and intima-media thickness in obese adolescent girls. J Clin Endocrinol Metab (2011) 1.65
Progression of coronary artery calcium in men affected by human immunodeficiency virus infection. Int J Cardiovasc Imaging (2011) 1.63
Inflammation-associated insulin resistance: differential effects in rheumatoid arthritis and systemic lupus erythematosus define potential mechanisms. Arthritis Rheum (2008) 1.63
Determinants of progressive vascular calcification in haemodialysis patients. Nephrol Dial Transplant (2004) 1.61
Demographics of blood pressure and hypertension in children on renal replacement therapy in Europe. Kidney Int (2011) 1.61
Novel solid-state-detector dedicated cardiac camera for fast myocardial perfusion imaging: multicenter comparison with standard dual detector cameras. J Nucl Cardiol (2009) 1.60
Stimulation of the calcium-sensing receptor stabilizes the podocyte cytoskeleton, improves cell survival, and reduces toxin-induced glomerulosclerosis. Kidney Int (2011) 1.57
Prognostic value of number and site of calcified coronary lesions compared with the total score. JACC Cardiovasc Imaging (2008) 1.57
Inflammatory mediators and premature coronary atherosclerosis in rheumatoid arthritis. Arthritis Rheum (2009) 1.56
Abnormal circadian blood pressure regulation in children born preterm. J Pediatr (2007) 1.54
Effect of intensive versus moderate lipid-lowering therapy on epicardial adipose tissue in hyperlipidemic post-menopausal women: a substudy of the BELLES trial (Beyond Endorsed Lipid Lowering with EBT Scanning). J Am Coll Cardiol (2013) 1.54
Epicardial adipose tissue is an independent marker of cardiovascular risk in HIV-infected patients. AIDS (2011) 1.53
Behavioural abnormalities in children with nephrotic syndrome. Nephrol Dial Transplant (2010) 1.52
Continuous probabilistic prediction of angiographically significant coronary artery disease using electron beam tomography. Circulation (2002) 1.52
Antihypertensive and antiproteinuric efficacy of ramipril in children with chronic renal failure. Kidney Int (2004) 1.50
Relationship between carotid intima-media thickness and metabolic syndrome in adolescents. J Pediatr (2013) 1.49
Phosphorus levels are associated with subclinical atherosclerosis in the general population. Atherosclerosis (2008) 1.48
Development of a cardiovascular calcification index using simple imaging tools in haemodialysis patients. Nephrol Dial Transplant (2006) 1.46
Study design and subject baseline characteristics in the ADVANCE Study: effects of cinacalcet on vascular calcification in haemodialysis patients. Nephrol Dial Transplant (2010) 1.44
Continuous veno-venous single-pass albumin hemodiafiltration in children with acute liver failure. Pediatr Crit Care Med (2011) 1.43
The effect of sevelamer on the pharmacokinetics of cyclosporin A and mycophenolate mofetil after renal transplantation. Nephrol Dial Transplant (2004) 1.42
Hybrid myocardial imaging for risk stratification prior to kidney transplantation: added value of coronary calcium and epicardial adipose tissue. J Nucl Cardiol (2013) 1.41
A super-agonist of growth hormone-releasing hormone causes rapid improvement of nutritional status in patients with chronic kidney disease. Kidney Int (2009) 1.40
Inflammation assessment in patients with arthritis using a novel in vivo fluorescence optical imaging technology. Ann Rheum Dis (2012) 1.39
Leukocytes induce epithelial to mesenchymal transition after unilateral ureteral obstruction in neonatal mice. Am J Pathol (2007) 1.39
The pharmacokinetic-pharmacodynamic relationship for total and free mycophenolic Acid in pediatric renal transplant recipients: a report of the german study group on mycophenolate mofetil therapy. J Am Soc Nephrol (2002) 1.38
Altered morphologic properties of large arteries in children with chronic renal failure and after renal transplantation. J Am Soc Nephrol (2005) 1.37
Trends in the prevalence, awareness, treatment, and control of cardiovascular disease risk factors among noninstitutionalized patients with a history of myocardial infarction and stroke. Am J Epidemiol (2006) 1.36
Left ventricular geometry in children with mild to moderate chronic renal insufficiency. J Am Soc Nephrol (2005) 1.36
Utility of the Framingham risk score to predict the presence of coronary atherosclerosis in patients with rheumatoid arthritis. Arthritis Res Ther (2006) 1.31
Two year comparison of sevelamer and calcium carbonate effects on cardiovascular calcification and bone density. Nephrol Dial Transplant (2005) 1.29
Disruption of PTPRO causes childhood-onset nephrotic syndrome. Am J Hum Genet (2011) 1.28
Consensus guidelines for the prevention and treatment of catheter-related infections and peritonitis in pediatric patients receiving peritoneal dialysis: 2012 update. Perit Dial Int (2012) 1.28
High coronary artery calcium scores pose an extremely elevated risk for hard events. J Am Coll Cardiol (2002) 1.27
Epicardial adipose tissue volume and coronary artery calcium to predict myocardial ischemia on positron emission tomography-computed tomography studies. J Nucl Cardiol (2010) 1.25
Comparison of prognostic usefulness of coronary artery calcium in men versus women (results from a meta- and pooled analysis estimating all-cause mortality and coronary heart disease death or myocardial infarction). Am J Cardiol (2007) 1.24
Novel cardiovascular risk factors in premature coronary atherosclerosis associated with systemic lupus erythematosus. J Rheumatol (2008) 1.24
Coronary artery calcium as a measure of biologic age. Atherosclerosis (2005) 1.24
Timing and outcome of renal replacement therapy in patients with congenital malformations of the kidney and urinary tract. Clin J Am Soc Nephrol (2012) 1.24
Diagnosis, assessment, and treatment of bone turnover abnormalities in renal osteodystrophy. Am J Kidney Dis (2004) 1.23
Peritonitis in children who receive long-term peritoneal dialysis: a prospective evaluation of therapeutic guidelines. J Am Soc Nephrol (2007) 1.23
Detection of high-risk young adults and women by coronary calcium and National Cholesterol Education Program Panel III guidelines. J Am Coll Cardiol (2005) 1.22